The role of fibrinolysis in the pathogenesis of the haemorrhagic syndrome produced by virulent isolates of African swine fever virus.
The activity of several proteins involved in fibrinolysis and the morphological changes in the blood vessel walls of pigs infected with highly virulent (Malawi'83) and moderately virulent (Dominican Republic '78-DR'78) ASF virus isolates were determined. Pigs infected with the Malawi'83 virus developed an increased fibrinolytic activity due to high plasma levels of tissue-plasminogen activator (t-PA) of 71.3 +/- 22.8 IU/ml (mean +/- SD), which correlated well with an increased activation of interstitial capillary endothelial cells and high levels of 1150 +/- 73.6 nM of fibrin monomer in the circulation. Animals infected with DR'78 virus, in contrast, showed an inhibition of fibrinolysis in the late stages of disease with almost a 5-fold increase of plasminogen activator inhibitor (PAI) activity of 196.0 AU/ml. These results suggest that activation of the fibrinolytic system in pigs infected with the Malawi'83 virus is probably due to increased formation and deposition of fibrin in the circulation, contributing to an increased bleeding tendency and higher mortality. On the contrary, animals infected with DR'78 virus developed an inhibition of fibrinolysis and thus a reduction in bleeding.
Villeda
C J
CJ
Centro de Biología Molecular (CSIC-UAM), Facultad de Ciencias, Universidad Autónoma de Madrid, Spain.
Gómez-Villamandos
J C
JC
Williams
S M
SM
Hervás
J
J
Wilkinson
P J
PJ
Viñuela
E
E
D000208:Acute Disease; D000357:African Swine Fever / Q000097:blood* / Q000150:complications / Q000473:pathology; D000358:African Swine Fever Virus / Q000472:pathogenicity*; D000818:Animals; D004487:Edema / Q000209:etiology; D005337:Fibrin / Q000032:analysis; D005342:Fibrinolysis; D006470:Hemorrhage / Q000209:etiology* / Q000503:physiopathology; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D015849:Plasminogen Inactivators / Q000032:analysis; D013552:Swine; D013577:Syndrome; D013927:Thrombosis / Q000209:etiology / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000032:analysis; D014774:Virulence
D015849:Plasminogen Inactivators; D005337:Fibrin; D010959:Tissue Plasminogen Activator